http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-172979-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_beb556082df8b4e173b44cfac134161e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
filingDate 2010-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81e2f9ce01eee4d475a33f1e85d4eeb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5fdf61b7a5ac9c0b21a840b7c32b4a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2414baa071cc5cafb687dd33e5cec6f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10514ec25e5e8fc3717a06e86561f78d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d659717d40f0ac1eb1b0cae8ad49fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_961163f79083831ceb680b7bbf164b10
publicationDate 2011-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SG-172979-A1
titleOfInvention Compound having tumor-resident property
abstract A novel compound which specifically resides in a tumor, a method for allowing it to reside in a tumor, and a method for detecting, diagnosing, and treatingtumor with use thereof are provided. The present invention relates to a compound represented by chemical formula (I)RR54, 0ID •°"‘,./--C--,,‘4 A 1/4-1 (I)A310 wherein R is an anionic group binding to hydrogen, R1is OH, OCOH, OCO(CH2)hCH3, or an acting group, 'h being an integer of 0 or more, R2 is H, OH, OCOH, OCO(CH2)1CH3, or an acting group, i being an integer of 0 or more, R3 is OH, SO3H, or an acting group, R4 is15 OH, SO3H, or an acting group, and R5 is OH, SO3H, or an acting group, at least one of R1, R2, R3, R4, and R5containing an acting group, or pharmaceutically acceptable salts thereof.
priorityDate 2009-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 26.